Covid-19 Saliva Screening Test Potential Market Is Estimated To Expand At A CAGR Of 4.8% From 2021 To 2023

 COVID-19 Saliva Screening Test Potential Industry Overview

The global COVID-19 saliva screening test potential market size is expected to reach USD 3,406.2 billion by 2023, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 4.8% from 2021 to 2023. The rise in demand for rapid, efficient, saliva-based screening tests has positively impacted market growth.

This is primarily due to the various advantages offered by saliva-based tests, increasing product approvals by regulatory bodies, and a paradigm shift toward point-of-care testing. The fluorescence-labeled antigen/antibodies test is one of the recent saliva-based COVID-19 screening tests in the market which is based on the principles of fluorescence detection, biochemistry, robotics automation, and cloud computing.

 

As the number of people visiting public places is increasing and reaching pre-pandemic statistics in a few countries, there is a growing demand for rapid, point-of-care COVID-19 tests to mitigate viral transmission from asymptomatic people. This has enhanced the R&D for the development of simple yet effective saliva-based tests and is expected to create lucrative opportunities for several developers.

 

COVID-19 Saliva Screening Test Potential Market Segmentation

Grand View Research has segmented the global COVID-19 saliva screening test potential market on the basis of location, technology, mode, and region:

Based on the Location Insights, the market is segmented into Travel Stations, Sports Arenas, Concert Halls, Shopping Malls and Centers, Amusement Parks, Corporate Campus Environments, Universities & Colleges, and Factories.

  • Unlike other low-throughput or individual screening solutions, saliva-based screening tests can be easily implemented at various locations such as travel stations, sports arenas, concert halls, shopping malls, amusement parks, corporate campus environments, universities and colleges, and manufacturing factories.

 

  • Amid the ongoing SARS-CoV-2 pandemic, air travel has fallen sharply, leading to a significant reduction in foot traffic at airports. This has severely impacted the economy leading to the screening of passengers becoming a necessity for airports and airlines to curb virus transmission.

 

Based on the Technology Insights, the market is segmented into Fluorescence-labeled antigen/antibodies testing, RT-PCR, and CRISPR-Cas9.

  • The fluorescence-labeled antigen/antibodies testing segment dominated the market for COVID-19 saliva screening test potential and accounted for the largest revenue share of 99.9% in 2020. Fluorescence-labeled antigen/antibodies testing LLC makes use of the CompleTest platform to diagnose an array of viral infections, including SARS-COV-2. 

 

  • The U.S.FDA has characterized these tests as rapid and suitable for point-of-care diagnosis, aimed at ramping up testing capacity, especially in the U.S. Acknowledgment of the pivotal role of antigen-based COVID-19 tests by the FDA has provided profitable opportunities for the expansion of Fluorescence-labeled antigen/antibodies testing’s business.

 

Based on the Mode Insights, the market is segmented into Centralized Testing, and Decentralized Testing.

  • The decentralized testing segment dominated the market COVID-19 saliva screening test potential and accounted for the largest revenue share of 96.2% in 2020. Increasing adoption of saliva-based COVID-19 screening tests by several developers contributes to the revenue generated by this segment.

 

  • Centralized settings can play an integral role in the saliva-based diagnosis of SARS-CoV-2 infections, as these are not rapid tests that can be performed near the patient. Ease of sample collection, minimization of collection supplies required for saliva testing, reduced tests in the testing protocol, and access to instruments are some of the reasons that can be attributed to the strong focus on saliva-based COVID-19 diagnosis across centralized settings.

 

COVID-19 Saliva Screening Test Potential Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Key Companies & Market Share Insights

The market COVID-19 saliva screening test potential is expected to witness tremendous growth in the coming years. The increasing number of product approvals, emergency use authorizations by regulatory bodies, and technological collaborations between operating players have intensified market growth.

In February 2021, George Mason University in Fairfax initiated COVID-19 testing using the Fluidigm Corporation’s Advanta Dx SARS-CoV-2 RT-PCR Assay. This assay is being used on the Fluidigm Biomark HD system. In addition, in April 2021, Quidel Corporation signed a distribution agreement with McKesson Corporation to increase the availability of at-home COVID-19 testing services. Such initiatives have increased market potential for saliva-based COVID-19 screening tests. Some of the prominent players in the global Covid-19 saliva screening test potential market include:

  • ARUP Laboratories
  • Vatic Health
  • MOgene
  • Psomagen Inc.
  • DxTerity Diagnostics, Inc.
  • Ambry Genetics
  • Fluidigm Corporation
  • Phosphorus Diagnostics LLC
  • Gravity Diagnostics
  • DNA Genotek, Inc.
  • Quidel Corporation
  • Abbott
  • LumiraDX
  • FluroTech Ltd.

 

Order a free sample PDF of the COVID-19 Saliva Screening Test Potential Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more